Frank L van de Veerdonk
Overview
Explore the profile of Frank L van de Veerdonk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
261
Citations
17772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brouwer M, Karami Z, Keating S, Vrijmoeth H, Lemmers H, Dijkstra H, et al.
Ticks Tick Borne Dis
. 2025 Jan;
16(1):102442.
PMID: 39879745
Interferons (IFNs) are important signaling molecules in the human immune response against micro-organisms. Throughout initial Borrelia burgdorferi sensu lato (B. burgdorferi s.l.) infection in vitro, inadequate IFN-γ production results in...
2.
Rosati D, Valentine M, Bruno M, Pradhan A, Dietschmann A, Jaeger M, et al.
Virulence
. 2025 Jan;
16(1):2451165.
PMID: 39843417
Vulvovaginal candidiasis (VVC) is one of the most common infections caused by . VVC is characterized by an inadequate hyperinflammatory response and clinical symptoms associated with colonization of the vaginal...
3.
Netea M, van de Veerdonk F, Giamarellos-Bourboulis E
JAMA
. 2025 Jan;
333(8):661-662.
PMID: 39761040
No abstract available.
4.
Aksu M, van der Ent T, Zhang Z, Riza A, de Nooijer A, Ricano-Ponce I, et al.
J Infect
. 2024 Oct;
89(6):106300.
PMID: 39357572
Objectives: IL-1α/β and TNF are closely linked to the pathology of severe COVID-19 and sepsis. The soluble forms of their receptors, functioning as decoy receptors, exhibit inhibitory effects. However, little...
5.
Seldeslachts L, Staels F, Gkountzinopoulou M, Jacobs C, Tielemans B, Vanhoffelen E, et al.
EBioMedicine
. 2024 Oct;
108:105347.
PMID: 39353282
Background: Influenza-associated pulmonary aspergillosis (IAPA) is a severe fungal superinfection in critically ill influenza patients that is of incompletely understood pathogenesis. Despite the use of contemporary therapies with antifungal and...
6.
Feys S, Carvalho A, Clancy C, Gangneux J, Hoenigl M, Lagrou K, et al.
Lancet Respir Med
. 2024 Jul;
12(9):728-742.
PMID: 39025089
Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are increasingly recognised as important complications in patients requiring intensive care for severe viral pneumonia. The diagnosis can typically be made...
7.
Li X, Paccoud O, Chan K, Yuen K, Manchon R, Lanternier F, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae316.
PMID: 38947739
is an opportunistic fungal pathogen that can cause disseminated infection with predominant central nervous system involvement in patients with compromised immunity. Biologics are increasingly used in the treatment of neoplasms...
8.
Feys S, Cardinali-Benigni M, Lauwers H, Jacobs C, Stevaert A, Goncalves S, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(10):1230-1242.
PMID: 38865563
The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA) has yet to be explored. To...
9.
Koenen H, Kouijzer I, de Groot M, Peters S, Lobeek D, van Genugten E, et al.
Front Med (Lausanne)
. 2024 May;
11:1414415.
PMID: 38813383
No abstract available.
10.
van Leeuwen L, Grobben M, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J, et al.
Front Immunol
. 2024 May;
15:1390022.
PMID: 38698851
Purpose: Previous studies have demonstrated that the majority of patients with an inborn error of immunity (IEI) develop a spike (S)-specific IgG antibody and T-cell response after two doses of...